As part of the world-leading pharmaceutical trade show CPHI in Frankfurt, BLOK Management, together with LLB Banking and Gowling WLG, hosted a high-profile expert evening on October 27, focusing on the future of Radiopharma and Artificial Intelligence in the pharmaceutical industry.

As host, BLOK Management deliberately brought together decision-makers, founders, and leading scientists from the pharmaceutical, biotech, investment, and legal sectors to foster interdisciplinary dialogue between innovation, funding, and execution.

Two expert-led panel discussions highlighted the key innovation areas in the industry:

Radiopharma – From Vision to Reality
Can radiopharmaceuticals become the third pillar of oncology?

Featuring:

AI in Pharma – Hype or Game-Changer?
How is artificial intelligence transforming drug development?

Featuring:

The event once again highlighted BLOK Management’s role as an active enabler of innovation in the life sciences and healthcare sector. Through targeted networking, strategic insights, and peer-level exchanges, BLOK creates lasting value for companies, investors, and research partners.